Click Here to Corporate video Transforming lives...
Through Quality
Transforming lives of people through quality and innovative
healthcare solutions to ensure accessibility to more people.
Annual Communique 2023

Therapeutic solutions for well-being and life. We are focused, so our patients can live their life to the fullest.

MEDICAMEN Biotech Limited (MBL) is committed to providing quality medicines at an affordable cost through relentless pursuit of excellence in its operations, product quality, documentation and service.

READ MORE
14
100

Product Approvals in Emerging Markets

4

State-of-the-Art Manufacturing Facility(API, FDF)

500

Employees

25

Oncology Products in pipeline

30

Regulatory Agency Approvals

35

Total Products in pipeline for EU and Australia

OFFERINGS

Committed to providing solutions to the pharmaceutical industry across the value chain

Over the last decade, Medicamen has emerged as an integrated Pharmaceutical and Life Sciences Solution Provider offering products & services to its customers across the globe.

CANCER CARE

CARDIOLOGY

CNS

DIABETOLOGY

ANTI-MALARIAL

VITAMINS

ANTIBIOTICS

PAIN

Dummy_Image12

RESEARCH AND DEVELOPMENT

Fostering a culture of innovation through collaboration for developing enhanced solutions

We believe that our R&D has led, and will continue to lead to new, innovative processes that can increase the efficiencies of production including developing cost effective manufacturing processes, as well as address opportunities that we have identified in the global market for our businesses.

MEDICAMEN BIOTECH IN NEWS

Latest Medicamen News and Updates

1_news
NEWS UPDATE

Medicamen Biotech zooms by more than 16 per cent; do you own it?

Find More... 

BSE/NSE LISTING

Medicamen Ltd. Live BSE Share Price today.

INVESTOR INFORMATION

Medicamen Financial Information

CORPORATE PROFILE

Corporate Profile available for download.

NEWS UPDATE

Listing Of Equity Shares of Medicamen Biotech Limited on National Stock Exchange Of India Limited ('NSE')